Inducing cellular immune responses to carcinoembryonic...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 38/04 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) C07H 21/02 (2006.01) C07H 21/04 (2006.01) C07K 4/12 (2006.01) C07K 7/00 (2006.01) C07K 9/00 (2006.01) C07K 14/705 (2006.01)

Patent

CA 2392764

This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare carcino-embryonic antigen (CEA) epitopes, and to develop epitope-based vaccines directed towards CEA-bearing tumors. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of cancer.

L'invention fait appel à nos connaissances des mécanismes par lesquels un antigène est reconnu par des lymphocytes T, pour identifier et préparer des épitopes de l'antigène carcinoembryonnaire (ACE) et pour mettre au point des vaccins sur la base de ces épitopes dirigés contre les tumeurs contenant des ACE. Plus précisément, cette demande concerne la découverte de compositions pharmaceutiques et leurs méthodes d'utilisation dans la prévention et le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inducing cellular immune responses to carcinoembryonic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inducing cellular immune responses to carcinoembryonic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inducing cellular immune responses to carcinoembryonic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1630874

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.